AI start-up Atomwise raises $45 million | March 12, 2018 Issue - Vol. 96 Issue 11 | Chemical & Engineering News
Volume 96 Issue 11 | p. 19 | Concentrates
Issue Date: March 12, 2018

AI start-up Atomwise raises $45 million

By Ryan Cross
Department: Business
Keywords: Drug discovery, AI, artificial intelligence

Atomwise is the latest drug discovery start-up to raise cash on the promise of finding better compounds faster via artificial intelligence. The San Francisco-based company was founded in 2012 but just announced raising $45 million in series A funding last week. The financing was led by Monsanto Growth Ventures, Data Collective, and B Capital Group. Atomwise says it has “over 50 distinct molecular discovery programs” in partnerships with Monsanto, drug firms, and universities.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment